Lynne Verselis

Director, Clinical Development at Prevail Therapeutics

Lynne Verselis is a seasoned professional in the field of clinical development with extensive experience in the biotechnology and pharmaceutical industries. Since January 2019, Lynne has held various roles at Prevail Therapeutics, currently serving as Director of Clinical Development. Prior to this, Lynne worked at Roche for over a decade, initially as Principal Scientist, where responsibilities included developing and validating biologic compounds, and later as Clinical Scientist, providing support for early phase clinical trials in CNS indications. Lynne's academic credentials include a Mini-MBA in Leading Biopharma Innovation from Rutgers Business School, an M.A. in Biology from Hofstra University, and a B.S. in Zoology from the University of Michigan.

Location

New York, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Prevail Therapeutics

Prevail Therapeutics are developing novel gene therapies that target the root genetic causes of Parkinson’s disease and other neurodegenerative disorders.


Industries

Employees

51-200

Links